Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement

Over the last two decades, the utilization of various novel therapies in the upfront or salvage settings has continued to improve survival outcomes for patients with Multiple Myeloma (MM). Thus, the conventional role for hematopoietic stem cell transplantation (HSCT) in MM either in the form of an a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Bone Marrow Transplant
Main Authors: Gonsalves, Wilson I., Buadi, Francis K., Ailawadhi, Sikander, Bergsagel, P. Leif, Chanan Khan, Asher A., Dingli, David, Dispenzieri, Angela, Fonseca, Rafael, Hayman, Susan R., Kapoor, Prashant, Kourelis, Taxiarchis V., Lacy, Martha Q., Larsen, Jeremy T., Muchtar, Eli, Reeder, Craig B., Sher, Taimur, Stewart, A. Keith, Warsame, Rahma, Go, Ronald S., Kyle, Robert A., Leung, Nelson, Lin, Yi, Lust, John A., Russell, Stephen J., Zeldenrust, Stephen R., Fonder, Amie L., Hwa, Yi L., Hobbs, Miriam A., Mayo, Angela A., Hogan, William J., Rajkumar, S. Vincent, Kumar, Shaji K., Gertz, Morie A., Roy, Vivek
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2018
Assuntos:
Review Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6463224/
https://ncbi.nlm.nih.gov/pubmed/29988062
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41409-018-0264-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados